{"id":250,"date":"2017-07-06T15:38:31","date_gmt":"2017-07-06T20:38:31","guid":{"rendered":"https:\/\/blog.unmc.edu\/infectious-disease\/?p=250"},"modified":"2017-07-06T15:39:13","modified_gmt":"2017-07-06T20:39:13","slug":"hiv-prevention-are-you-prepared","status":"publish","type":"post","link":"https:\/\/blog.unmc.edu\/infectious-disease\/2017\/07\/06\/hiv-prevention-are-you-prepared\/","title":{"rendered":"HIV prevention &#8211; Are you PrEPared?"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\"><p>HIV pre-exposure prophylaxis (PrEP) is the strategy of administering antiretrovirals to HIV uninfected, at-risk individuals in order to <strong><em>prevent <\/em><\/strong>HIV infection. Tenofovir-emtricitabine (Truvada) was approved for HIV PrEP by the FDA in 2012 and is over 90% effective in preventing HIV infection when taken as directed.<\/p>\n<p>UNMC\u2019s HIV clinic has been offering HIV PrEP for a few years and demand is steadily increasing, but patients often arrive too late. Recently, we saw a patient with newly diagnosed HIV who had unsuccessfully tried to obtain PrEP from his primary care provider just months before his diagnosis.<\/p>\n<p>Although no single intervention is going to end the HIV epidemic, we have a chance at changing the course of the epidemic and significantly reducing the number of new HIV infections with PrEP.<\/p>\n<p>Providers from UNMC\u2019s HIV team are eager to teach others how to prescribe and monitor patients on PrEP and partnered with <a href=\"https:\/\/www.unomaha.edu\/\">University of Nebraska Omaha<\/a>, the <a href=\"http:\/\/dhhs.ne.gov\/Pages\/default.aspx\">Nebraska Department of Health and Human Service<\/a>s and the <a href=\"http:\/\/www.nap.org\/\">Nebraska AIDS Project<\/a> to provide educational seminars across the state in the months of May and June.<\/p>\n<p><strong>Did you miss the seminars?<\/strong> Find additional resource to learn about PrEP <a href=\"https:\/\/www.practicepointcme.com\/HIV\/optimal-management-of-hiv-disease-hepatitis-br-clinical-conference-xxv-opman-enduring-video-archive-8358\">here<\/a>\u00a0and <a href=\"https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html\">here<\/a>. Look for mini modules to update your HIV knowledge in general? Try <a href=\"https:\/\/www.practicepointcme.com\/HIV\">these<\/a>!<\/p>\n<p>&nbsp;<\/p>\n<p><em>Content courtesy of Dr. Bares and Sara Weber. Learn more about the UNMC HIV clinic <a href=\"https:\/\/unmc.edu\/intmed\/divisions\/id\/hiv\/\">here<\/a>.<\/em><\/p>\n<form name=\"s2form\" method=\"post\" action=\"https:\/\/blog.unmc.edu\/infectious-disease\/subscribe2\/\"><input type=\"hidden\" name=\"ip\" value=\"216.73.216.108\" \/><span style=\"display:none !important\"><label for=\"firstname\">Leave This Blank:<\/label><input type=\"text\" id=\"firstname\" name=\"firstname\" \/><label for=\"lastname\">Leave This Blank Too:<\/label><input type=\"text\" id=\"lastname\" name=\"lastname\" \/><label for=\"uri\">Do Not Change This:<\/label><input type=\"text\" id=\"uri\" name=\"uri\" value=\"http:\/\/\" \/><\/span><p><label for=\"s2email\">Your email:<\/label><br><input type=\"email\" name=\"email\" id=\"s2email\" value=\"Enter email address...\" size=\"20\" onfocus=\"if (this.value === 'Enter email address...') {this.value = '';}\" onblur=\"if (this.value === '') {this.value = 'Enter email address...';}\" \/><\/p><p><input type=\"submit\" name=\"subscribe\" value=\"Subscribe\" \/>&nbsp;<input type=\"submit\" name=\"unsubscribe\" value=\"Unsubscribe\" \/><\/p><\/form>\r\n\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>HIV pre-exposure prophylaxis (PrEP) is the strategy of administering antiretrovirals to HIV uninfected, at-risk individuals in order to prevent HIV infection. Tenofovir-emtricitabine (Truvada) was approved for HIV PrEP by the FDA in 2012 and is over 90% effective in preventing HIV infection when taken as directed. UNMC\u2019s HIV clinic has been offering HIV PrEP for [&hellip;]<\/p>\n","protected":false},"author":532,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_s2mail":"yes","footnotes":""},"categories":[1],"tags":[17,3],"class_list":["post-250","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-unmchiv","tag-unmcid"],"_links":{"self":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts\/250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/users\/532"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/comments?post=250"}],"version-history":[{"count":3,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts\/250\/revisions"}],"predecessor-version":[{"id":273,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/posts\/250\/revisions\/273"}],"wp:attachment":[{"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/media?parent=250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/categories?post=250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-json\/wp\/v2\/tags?post=250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}